Mission Statement, Vision, & Core Values of 22nd Century Group, Inc. (XXII)

Mission Statement, Vision, & Core Values of 22nd Century Group, Inc. (XXII)

US | Consumer Defensive | Tobacco | NASDAQ

22nd Century Group, Inc. (XXII) Bundle

Get Full Bundle:

TOTAL: $121 $71

What drives a company striving to lead the fight against nicotine dependence, especially when it reported a net revenue of just $4.0 million in the fourth quarter of 2024? Is it purely about the bottom line, or is there a deeper purpose at play? Understanding the mission, vision, and core values of 22nd Century Group, Inc. (XXII) provides insight into the principles guiding their pursuit of a healthier future through plant biotechnology. But how do these ideals translate into tangible actions and financial results, particularly when facing an operating loss of $4.1 million in the same quarter?

22nd Century Group, Inc. (XXII) An Overview of

22nd Century Group, Inc. (XXII) is an agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through plant science. They use genetic engineering and plant breeding to develop products that address significant unmet needs in both the tobacco and cannabis industries.

The company's primary focus is on very low nicotine content (VLNC) tobacco cigarettes, which are designed to help smokers reduce their nicotine consumption and quit smoking more easily. 22nd Century Group holds exclusive global licenses to key technologies that allow for the production of tobacco with nicotine levels reduced by up to 97%. This technology has the potential to significantly reduce the addictiveness of cigarettes and the harm caused by smoking.

Beyond tobacco, 22nd Century Group is also involved in the development of hemp/cannabis products with unique cannabinoid profiles. They are working to create new varieties of hemp/cannabis with enhanced levels of specific cannabinoids, such as CBD, CBG, and CBN, for use in a variety of consumer products.

Here is a summary of the company's key areas:

  • Tobacco Harm Reduction: Developing and commercializing VLNC cigarettes to reduce nicotine addiction and smoking-related harm.
  • Hemp/Cannabis: Creating new hemp/cannabis varieties with unique cannabinoid profiles for consumer products.
  • Plant Biotechnology: Using genetic engineering and plant breeding to develop innovative products in the tobacco and cannabis industries.

For more in-depth information, you can explore this resource: 22nd Century Group, Inc. (XXII): History, Ownership, Mission, How It Works & Makes Money

In 2024, 22nd Century Group achieved significant milestones, particularly with its VLNC cigarettes. The company reported record-breaking revenue, driven primarily by increased sales of its VLNC cigarettes in the U.S. market. The company's financial performance reflects its successful execution of strategic initiatives and growing demand for its products.

Key financial highlights from the latest reports include:

  • Increased Revenue: Significant year-over-year revenue growth, driven by VLNC cigarette sales.
  • Market Expansion: Successful expansion into new geographic markets and retail channels.
  • Strategic Investments: Continued investments in research and development to further enhance its product portfolio.

22nd Century Group is a leader in the agricultural biotechnology space, particularly in the areas of tobacco harm reduction and innovative hemp/cannabis solutions. Its commitment to innovation, scientific rigor, and product quality has positioned it as a key player in these rapidly evolving industries. To understand the reasons behind Company's success, continue reading to learn more.

22nd Century Group, Inc. (XXII) Mission Statement

22nd Century Group, Inc. (Nasdaq: XXII) is a leading agricultural biotechnology company focused on improving health and wellness through plant science. The company's primary mission in tobacco is to greatly reduce the harm caused by smoking by bringing their reduced nicotine content tobacco cigarettes – containing 95% less nicotine than conventional cigarettes – to adult smokers in the U.S. and international markets.

The company is focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. 22nd Century Group employs plant breeding technologies, including genetic engineering, gene-editing, and molecular breeding to deliver solutions for the life science and consumer products industries.

The ingenuity and talent of 22nd Century Group's employees serve as a testament to their dynamic and flexible culture, driven by commitment, innovation, and stability. The company's scientists, engineers, sales and marketing teams, operations specialists, accountants, legal professionals, and managers are deeply committed to their health-based mission and the shared vision of improving lives, reducing preventable deaths, and combating nicotine addiction.

22nd Century Group's mission is to sell the last cigarette before the 22nd Century. The company created its flagship product, the VLN® cigarette, to give traditional cigarette smokers an authentic and familiar alternative that helps them take control of their nicotine consumption. VLN® cigarettes have 95% less nicotine than traditional cigarettes and have been proven to greatly reduce nicotine consumption.

Our extensive patent portfolio has been developed to ensure we have the only low nicotine combustible cigarette in the United States and critical international markets.

22nd Century Group, Inc. is the pioneering nicotine harm reduction company in the tobacco industry enabling smokers to take control of their nicotine consumption.

22nd Century Group is on track to become EBITDA profitable as early as the first quarter of 2025. The company recently regained compliance with the shareholder's equity requirement, and this last step will enable them to regain compliance with the Nasdaq minimum bid price requirement as they continue to work toward creating long-term shareholder value.

Our primary mission in tobacco is to greatly reduce the harm caused by smoking by bringing our reduced nicotine content tobacco cigarettes – containing 95% less nicotine than conventional cigarettes – to adult smokers in the U.S. and international markets.

22nd Century Group's mission is supported by several core principles:

  • Commitment: A dedication to maximizing professional opportunities for all employees, fostering diversity, and empowering them to reach their highest potential.
  • Innovation: Encouraging new ideas and approaches to address the challenges of changing markets, customer needs, and evolving technologies.
  • Stability: Ensuring a respectful and inclusive work environment through established employee standards and ethical guidelines.

These core principles have propelled 22nd Century Group into new markets and territories, as demonstrated by their acquisition of GVB Biopharma and RX Pharmatech.

For more insights into 22nd Century Group, Inc.'s history, mission, and operations, you can visit: 22nd Century Group, Inc. (XXII): History, Ownership, Mission, How It Works & Makes Money

22nd Century Group, Inc. (XXII) Vision Statement

To fully understand 22nd Century Group, Inc. (XXII), it is crucial to examine its mission, vision, and core values. These elements provide a comprehensive view of the company's goals, aspirations, and guiding principles. As of April 2025, the company focuses on improving health through plant biotechnology. Let's delve into each of these components to gain a deeper insight into XXII.

Mission Statement

The mission statement of 22nd Century Group is to improve health with innovative plant biotechnology. This is reflected in their focus on reducing the harm caused by smoking through reduced nicotine cigarettes and striving to improve health and wellness through modern plant breeding. This mission drives their strategic initiatives and product development.

  • Reducing the harm caused by smoking through reduced nicotine cigarettes.
  • Improving health and wellness through modern plant breeding.

Vision Statement

The vision of 22nd Century Group is to deliver innovative solutions to improve health and wellness through plant biotechnology. The company aims to lead in creating products that address significant health issues and enhance overall well-being. This vision is forward-looking, setting the direction for the company's long-term goals and aspirations. As of the fiscal year 2024, 22nd Century Group is focused on:

  • Reducing nicotine in cigarettes to non-addictive levels.
  • Developing improved hemp/cannabis plants to deliver desirable cannabinoid profiles and other value-added traits.

Core Values

22nd Century Group operates on a set of core values that guide its actions and decisions. These values reflect the company's commitment to innovation, health, and integrity. While specific details of their core values are less explicitly detailed in their filings, their actions and stated objectives suggest a strong emphasis on:

  • Innovation: Continuously seeking new and improved solutions through plant biotechnology.
  • Health Focus: Prioritizing products and solutions that promote health and wellness.
  • Integrity: Maintaining high ethical standards in all operations and interactions.

These values are evident in their pursuit of reduced nicotine cigarettes and their work in developing hemp/cannabis plants for health benefits.

For more insights into the company's investor profile, you can explore this resource: Exploring 22nd Century Group, Inc. (XXII) Investor Profile: Who’s Buying and Why?

22nd Century Group, Inc. (XXII) Core Values of

While specific, formally published core values for 22nd Century Group, Inc. aren't readily available in my current search results, we can analyze their mission and activities to infer what likely drives their actions. This approach allows us to understand what principles guide the company, even without a dedicated list.

Based on available information, we can identify several key values that appear central to 22nd Century Group's operations:

  • Innovation: Evident in their focus on developing reduced nicotine tobacco and advanced plant biotechnology.
  • Health & Wellness: Demonstrated by their efforts to reduce the harm caused by smoking.
  • Scientific Rigor: Reflected in their reliance on research and development to create and validate their products.
  • Regulatory Compliance: Shown through their proactive engagement with the FDA and adherence to regulatory standards.
  • Sustainability: Implied by their work in plant biotechnology, which can contribute to more sustainable agricultural practices.

Let's explore each of these inferred values in more detail:

Innovation:

Innovation is at the heart of 22nd Century Group's mission. The company is dedicated to using innovative plant biotechnology to develop products that address significant public health and agricultural challenges. This commitment is evident in their development of reduced nicotine cigarettes, designed to help smokers reduce their nicotine consumption. According to their 2024 report, research and development expenses totaled $7.5 million, highlighting their ongoing investment in innovation. Their Modified Risk Tobacco Product (MRTP) application for VLN cigarettes showcases their innovative approach to harm reduction, aiming to provide smokers with a less addictive alternative.

Health & Wellness:

A core driver for 22nd Century Group appears to be improving public health, particularly by reducing the harm associated with smoking. Their primary focus on reduced nicotine cigarettes demonstrates this value. The company's VLN cigarettes, containing 95% less nicotine than conventional cigarettes, are designed to help smokers gradually reduce their dependence on nicotine. This aligns with the FDA's comprehensive plan for tobacco and nicotine regulation, which emphasizes reducing the addictiveness of cigarettes. In 2024, the company highlighted the potential for VLN cigarettes to significantly reduce smoking rates and improve public health outcomes, reflecting their dedication to health and wellness.

Scientific Rigor:

22nd Century Group places a strong emphasis on scientific research and evidence-based decision-making. Their product development process relies heavily on rigorous scientific studies to demonstrate the safety and efficacy of their products. For example, numerous independent studies have validated the reduced addictiveness of VLN cigarettes. The company also collaborates with leading researchers and institutions to further advance the science of tobacco harm reduction and plant biotechnology. Their commitment to scientific rigor ensures that their products are based on solid evidence and meet the highest standards of quality and safety.

Regulatory Compliance:

Operating in a highly regulated industry, 22nd Century Group prioritizes compliance with all applicable laws and regulations. They work closely with regulatory agencies, such as the FDA, to ensure that their products meet all requirements. Their MRTP application for VLN cigarettes demonstrates their proactive approach to regulatory compliance. The company has invested significant resources in preparing and submitting comprehensive scientific data to support their application. Their commitment to regulatory compliance ensures that their products are legally marketed and that they operate responsibly within the industry.

Sustainability:

While not explicitly stated, sustainability is an implicit value in 22nd Century Group's operations. Their work in plant biotechnology has the potential to contribute to more sustainable agricultural practices. For example, they are developing tobacco varieties that require less water and fertilizer, reducing the environmental impact of tobacco farming. Additionally, their focus on reducing the harm caused by smoking aligns with broader sustainability goals by promoting public health and well-being. As the company continues to grow and expand its operations, it is likely that sustainability will become an increasingly important value.

To gain a deeper understanding of the company, explore: 22nd Century Group, Inc. (XXII): History, Ownership, Mission, How It Works & Makes Money

DCF model

22nd Century Group, Inc. (XXII) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.